On July 23, 2009, Bristol-Myers Squibb Company (the "Company") issued a press release announcing its financial results for the second quarter of 2009. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. Also furnished and incorporated by reference are Exhibit 99.2, a supplemental investor presentation, and Exhibit 99.3, certain supplemental information, both of which are posted on the Company's website at www.bms.com.

On July 22, 2009, the Company and Medarex, Inc. issued a press release announcing that the companies have signed a definitive merger agreement that provides for the acquisition of Medarex, Inc. by the Company, for $16.00 per share in cash. A copy of the press release announcing the planned acquisition is filed as Exhibit 99.4 to this report and is incorporated herein by reference.

(d) Exhibits.

99.1    Press release of Bristol-Myers Squibb Company dated July 23, 2009.

99.2.   Supplemental investor presentation posted on Bristol-Myers Squibb
        Company's website at www.bms.com not included in the press release.

99.3.   Certain supplemental information posted on Bristol-Myers Squibb Company's
        website at www.bms.com not included in the press release.

99.4    Press release of Bristol-Myers Squibb Company and Medarex, Inc. dated July
        22, 2009.